Skip to main content

Advertisement

SpringerLink
Log in

Hypertension and dementia

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Hypertension is one of the principal risk factors for cerebrovascular diseases. Several epidemiologic studies have also indicated a positive correlation between cognitive decline or dementia and blood pressure level. Indeed, the results of most longitudinal studies show that cognitive functioning is often inversely proportional to blood pressure values measured 15 or 20 years previously. Cerebral infarcts, lacunae, and white matter changes are implicated in the pathogenesis of vascular dementia, but may also favor the development of Alzheimer’s disease. Microcirculation disorders and endothelial dysfunctions are also advanced to explain the deterioration in cognitive functions in hypertensive subjects. Data from recent therapeutic trials open the way to the prevention of dementia (vascular or Alzheimer’s type) by antihypertensive treatments and must be confirmed by other studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Snowdon DA, Greiner LH, Mortimer JA, et al.: Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813–817.

    Article  PubMed  CAS  Google Scholar 

  2. Elias MF, Wolf PA, d’Agostino RB, et al.: Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993, 138:353–364.

    PubMed  CAS  Google Scholar 

  3. Launer J, Masaki K, Petrovitch H, et al.: The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846–1851. The Honolulu-Asia Aging Study indicates a significant correlation between the systolic blood pressure measured at 40 to 50 years and the risk of cognitive impairment 25 years later in 3735 subjects, characterized by a relative risk of cognitive decline of 2.45 (95% CI 1.42–4.25) for patients with SBP at least 160 mm Hg.

    Article  PubMed  CAS  Google Scholar 

  4. Kilander L, Nyman H, Boberg M, et al.: Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998, 31:780–786. Cognitive functions assessed at the age of 70 years were negatively correlated with the blood pressure values measured at the age of 50 years in 999 men followed-up for 20 years. The higher blood pressure was, the poorer cognitive function is.

    PubMed  CAS  Google Scholar 

  5. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A: Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 1999, 53:1948–1952.

    PubMed  CAS  Google Scholar 

  6. Knopman D, Boland LL, Mosley T, et al., and the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42–48.

    PubMed  CAS  Google Scholar 

  7. Okumiya K, Matsubayashi K, Wada T, et al.: J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan. J Am Geriatr Soc 1997, 45:1032–1033.

    PubMed  CAS  Google Scholar 

  8. Glynn RJ, Beckett LA, Hebert LE, et al.: Current and remote blood pressure and cognitive decline. JAMA 1999, 281:438–445.

    Article  PubMed  CAS  Google Scholar 

  9. Bohannon AD, Fillenbaum GG, Pieper CF, et al.: Relationship of race/ethnicity and blood pressure to change in cognitive function. J Am Geriatr Soc 2002, 50:424–429.

    Article  PubMed  Google Scholar 

  10. Cacciatore F, Abete P, Ferrara N, et al.: Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998, 46:1343–1348.

    PubMed  CAS  Google Scholar 

  11. Skoog I, Lernfelt B, Landahl S, et al.: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141–1145. The authors studied the relationship between blood pressure measured at 70 years and the incidence of dementia 9 to 15 years later. The blood pressure values at age 70 were significantly higher in patients developing dementia between the ages of 79 and 85 years than in nondemented subjects.

    Article  PubMed  CAS  Google Scholar 

  12. Guo Z, Viitanen M, Fratiglioni L, Winblad B: Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996, 312:805–808.

    PubMed  CAS  Google Scholar 

  13. Launer LJ, Ross GW, Petrovitch H, et al.: Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000, 21:49–55.

    Article  PubMed  CAS  Google Scholar 

  14. Kivipelto M, Helkala EL, Laakso MP, et al.: Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ 2001, 322:1447–1451.

    Article  PubMed  CAS  Google Scholar 

  15. Qiu C, Winblad B, Viitanen M, Fratiglioni L: Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke 2003, 34:594–599.

    Article  PubMed  Google Scholar 

  16. Meyer JS, Judd BW, Tawaklna T, et al.: Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986, 256:2203–2209

    Article  PubMed  CAS  Google Scholar 

  17. Guo Z, Fratiglioni L, Zhu L, et al.: Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999, 56:991–996.

    Article  PubMed  CAS  Google Scholar 

  18. Murray MD, Lane KA, Gao S, et al.: Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 2002, 162:2090–2096.

    Article  PubMed  Google Scholar 

  19. Prince MJ, Bird AS, Blizard RA, Mann AH: Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s treatment trial of hypertension in older adults. BMJ 1996, 312:801–805.

    PubMed  CAS  Google Scholar 

  20. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264

    Article  Google Scholar 

  21. Di Bari M, Pahor M, Franse LV, et al.: Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001, 153:72–78.

    Article  PubMed  CAS  Google Scholar 

  22. Forette F, Seux M-L, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347–1351. The Syst-Eur substudy was run in nondemented patients with isolated systolic hypertension randomized to active (n = 1238) or placebo treatment (n = 1180). By intention-to-treat, the incidence of dementia was reduced by 50% from 7.7 in the placebo group to 3.7 cases per 1000 patient-years in the active treatment group.

    Article  PubMed  CAS  Google Scholar 

  23. Forette F, Seux ML, Staessen JA, et al., for the Systolic Hypertension in Europe Investigators: The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002, 162:2046–2052.

    Article  PubMed  Google Scholar 

  24. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033–1041.

    Article  Google Scholar 

  25. Tzourio C, Anderson C, Chapman N, et al., for the PROGRESS Collaborative Group: Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003 12,163:1069–1075. The randomized, placebo-controlled PROGRESS study was run on hypertensive or normotensive patients with a previous history of stroke. The results indicate after 4 years of follow-up, a significant reduction of 34% of dementia with active treatment in patients with recurrent stroke.

    Google Scholar 

  26. O’Neill C, Cowburn RF, Bonkale WL, et al.: Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer’s disease. Biochem Soc Symp 2001, 67:177–194.

    PubMed  CAS  Google Scholar 

  27. Pascale A, Etcheberrigaray R: Calcium alterations in Alzheimer’s disease: pathophysiology, models and therapeutic opportunities. Pharmacol Res 1999, 39:81–88.

    Article  PubMed  CAS  Google Scholar 

  28. Gould RJ, Murphy KM, Snyder SH: Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine. Brain Res 1985, 330:217–223.

    Article  PubMed  CAS  Google Scholar 

  29. Lopez-Arrieta JM, Birks J: Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2002, 3:CD000147.

  30. Lithell H, Hansson L, Skoog I, et al., for the SCOPE Study Group: The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003, 21:875–886.

    Article  PubMed  CAS  Google Scholar 

  31. Bulpitt C, Fletcher A, Beckett N, et al.: Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging 2001, 18:151–164.

    Article  PubMed  CAS  Google Scholar 

  32. Strandgaard S, Paulson OB: Cerebrovascular consequences of hypertension. Lancet 1994, 344:519–520.

    Article  PubMed  CAS  Google Scholar 

  33. Tatemichi TK, Desmond DW, Mayeux R, et al.: Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992, 42:1185–1193.

    PubMed  CAS  Google Scholar 

  34. Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al.: Clinical determinants of poststroke dementia. Stroke 1998, 29:75–81.

    PubMed  CAS  Google Scholar 

  35. Andersen G, Vestergaard K, Riis J, Ingeman-Nielsen M: Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis 1996, 6:363–369.

    Google Scholar 

  36. Tatemichi TK, Paik M, Bagiella E, et al.: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994, 44:1885–1891.

    PubMed  CAS  Google Scholar 

  37. Kokmen E, Whisnant JP, O’Fallon WM, et al.: Dementia after ischemic stroke. A population based study in Rochester, Minnesota (1960-1984). Neurology 1996, 46:154–159.

    PubMed  CAS  Google Scholar 

  38. Henon H, Pasquier F, Durieu I, et al.: Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997, 28:2429–2436.

    PubMed  CAS  Google Scholar 

  39. Longstreth WT Jr, Manolio TA, Arnold A, et al.: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996, 27:1274–1282.

    PubMed  Google Scholar 

  40. Breteler MMB, van Swieten JC, Bots ML, et al.: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994, 44:1246–1252.

    PubMed  CAS  Google Scholar 

  41. Hardy JA, Mann DM, Wester P, Winblad B: An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 1986, 7:489–502.

    Article  PubMed  CAS  Google Scholar 

  42. Hamet P, Richard L, Dam TV, et al.: Apoptosis in target organs of hypertension. Hypertension 1995, 26:642–648.

    PubMed  CAS  Google Scholar 

  43. Vagnucci AH Jr, Li WW: Alzheimer’s disease and angiogenesis. Lancet 2003, 361:605–608.

    Article  PubMed  CAS  Google Scholar 

  44. Arregui A, Perry EK, Rossor M, Tomlinson BE: Angiotensin converting nzyme in Alzheimer’s disease increased activity in caudate nucleus and cortical areas. J Neurochem 1982, 38:1490–1492.

    Article  PubMed  CAS  Google Scholar 

  45. Kokmen E, Beard CM, Chandra V, et al.: Clinical risk factors for Alzheimer’s disease: a population-based case-control study. Neurology 1991, 41:1393–1397.

    PubMed  CAS  Google Scholar 

  46. Prince M, Cullen M, Mann A: Risk factors for Alzheimer’s disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994, 44:97–104.

    PubMed  CAS  Google Scholar 

  47. Sparks DL, Scheff SW, Liu H, et al.: Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995, 131:162–169.

    Article  PubMed  CAS  Google Scholar 

  48. Yoshitake T, Kiyohara Y, Kato I, et al.: Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45:1161–1168.

    PubMed  CAS  Google Scholar 

  49. Morris MC, Scherr PA, Hebert LE, et al.: Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001, 58:1640–1646.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hôpital Broca, CHU Cochin Port-Royal, Université René Descartes, Paris V, 54/56 Rue Pascal, 75013, Paris, France

    Olivier Hanon MD, PhD

Authors
  1. Olivier Hanon MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marie Laure Seux MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hermine Lenoir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne Sophie Rigaud MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Françoise Forette MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanon, O., Seux, M.L., Lenoir, H. et al. Hypertension and dementia. Curr Cardiol Rep 5, 435–440 (2003). https://doi.org/10.1007/s11886-003-0104-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-003-0104-2

Keywords

Search

Navigation